159 related articles for article (PubMed ID: 1531075)
1. (+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
Baindur N; Tran M; Niznik HB; Guan HC; Seeman P; Neumeyer JL
J Med Chem; 1992 Jan; 35(1):67-72. PubMed ID: 1531075
[TBL] [Abstract][Full Text] [Related]
2. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
[TBL] [Abstract][Full Text] [Related]
3. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
[TBL] [Abstract][Full Text] [Related]
4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
5. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
[TBL] [Abstract][Full Text] [Related]
8. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
Pettersson I; Gundertofte K; Palm J; Liljefors T
J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365
[TBL] [Abstract][Full Text] [Related]
9. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
[TBL] [Abstract][Full Text] [Related]
10. Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
Pettersson I; Liljefors T; Bøgesø K
J Med Chem; 1990 Aug; 33(8):2197-204. PubMed ID: 1973733
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands.
Claudi F; Cingolani GM; Di Stefano A; Giorgioni G; Amenta F; Barili P; Ferrari F; Giuliani D
J Med Chem; 1996 Oct; 39(21):4238-46. PubMed ID: 8863801
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands.
Michaelides MR; Schoenleber R; Thomas S; Yamamoto DM; Britton DR; MacKenzie R; Kebabian JW
J Med Chem; 1991 Oct; 34(10):2946-53. PubMed ID: 1833546
[TBL] [Abstract][Full Text] [Related]
13. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
14. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.
Neumeyer JL; Kula NS; Bergman J; Baldessarini RJ
Eur J Pharmacol; 2003 Aug; 474(2-3):137-40. PubMed ID: 12921854
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Ryman-Rasmussen JP; Nichols DE; Mailman RB
Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
[TBL] [Abstract][Full Text] [Related]
16. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor.
Chumpradit S; Kung MP; Billings JJ; Kung HF
J Med Chem; 1991 Mar; 34(3):877-83. PubMed ID: 1825848
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
[TBL] [Abstract][Full Text] [Related]
19. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
[TBL] [Abstract][Full Text] [Related]
20. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
